Medical Devices

From exploding cameras to hazardous baby products, a massive wave of recalls exposes hidden dangers in everyday items. Here's what you need to know.

Facing dire financial warnings, Cosmos Health plans to sell its own facilities to fund a comeback. Is it a stroke of genius or a desperate final gambit?

The 3rd annual National STEM Festival brings PhD-level student research to D.C., connecting young builders with leaders to solve real-world workforce shortages.

A pharma revolution is brewing for Generalized Anxiety Disorder. As prevalence soars, novel therapies targeting new neural pathways promise to upend the market.

A 2027 CMS mandate and AI pioneers like Humata Health are racing to fix prior authorization. But can technology truly untangle healthcare's notorious red tape?

As NEXGEL prepares for a key investor conference, it faces a crucial test: convincing the market its advanced hydrogel tech can overcome recent financial hurdles.

New data showing a 300% spike in demand for Burmese prescription translations is a stark economic signal of a deeper demographic shift challenging U.S. healthcare.

Teva's new Eylea biosimilar hits Europe, a key move in its 'Pivot to Growth' strategy that promises to shake up the lucrative ophthalmology market.

With record device sales providing a solid financial base, RenovoRx nears a critical milestone in its high-stakes Phase III trial for a new pancreatic cancer therapy.

As AI sweeps through medicine, Gigi Yuen-Reed's recognition highlights a crucial strategy: building systems that empower, not replace, human expertise.

The renewed pact between PENTAX Medical and FUJIFILM promises over a decade of support for their EUS systems, a strategic move in a booming med-tech market.

The world's largest veterinary conference, VMX 2027, confronts industry burnout with its 'Off the Grid' theme, blending professional renewal with science.

A crucial CAP accreditation for its advanced CNS cancer test positions Plus Therapeutics to unlock new markets and redefine patient care with precision diagnostics.

With an FDA decision just weeks away, Ionis's olezarsen could redefine care for a debilitating condition, marking a pivotal moment for RNA-targeted medicine.

As Insulet unveils pivotal data, a deeper look reveals a strategy to not just improve tech, but to fundamentally change the daily reality of diabetes.

With new FDA clearances for 7-day wear and precise 1-unit dosing, CeQur's Simplicity patch is poised to disrupt the diabetes tech market. A deep dive.

From cryopreservation to ethical news, a new generation of entrepreneurs is emerging from the Southeast, proving that business can be a force for good.

Physicians are being warned about indemnification clauses in contracts that can shift immense liability. Here's what doctors need to know to avoid financial ruin.

For patients with fragile bones, spinal fusion is a high-stakes gamble. A new device offers a lifeline by anchoring screws with cement, but what does it mean for safety?

The market for T-cell malignancy treatments is set to surpass $1.8B, fueled by a pipeline of innovative drugs aiming to meet vast unmet patient needs.